Biolife Solutions Stock Shares Outstanding
BLFS Stock | USD 17.53 0.67 3.97% |
BioLife Solutions fundamentals help investors to digest information that contributes to BioLife Solutions' financial success or failures. It also enables traders to predict the movement of BioLife Stock. The fundamental analysis module provides a way to measure BioLife Solutions' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioLife Solutions stock.
Common Stock Shares Outstanding is likely to gain to about 45.9 M in 2024. BioLife | Shares Outstanding |
BioLife Solutions Company Shares Outstanding Analysis
BioLife Solutions' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current BioLife Solutions Shares Outstanding | 45.3 M |
Most of BioLife Solutions' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioLife Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
BioLife Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for BioLife Solutions is extremely important. It helps to project a fair market value of BioLife Stock properly, considering its historical fundamentals such as Shares Outstanding. Since BioLife Solutions' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BioLife Solutions' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BioLife Solutions' interrelated accounts and indicators.
Click cells to compare fundamentals
BioLife Shares Outstanding Historical Pattern
Today, most investors in BioLife Solutions Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BioLife Solutions' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of BioLife Solutions shares outstanding as a starting point in their analysis.
BioLife Solutions Shares Outstanding |
Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
BioLife Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, BioLife Solutions has 45.3 M of shares currently outstending. This is 74.91% lower than that of the Health Care Equipment & Supplies sector and 47.26% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 92.08% higher than that of the company.
BioLife Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioLife Solutions' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioLife Solutions could also be used in its relative valuation, which is a method of valuing BioLife Solutions by comparing valuation metrics of similar companies.BioLife Solutions is currently under evaluation in shares outstanding category among related companies.
BioLife Solutions Current Valuation Drivers
We derive many important indicators used in calculating different scores of BioLife Solutions from analyzing BioLife Solutions' financial statements. These drivers represent accounts that assess BioLife Solutions' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BioLife Solutions' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 314.9M | 1.1B | 1.4B | 773.2M | 710.4M | 746.0M | |
Enterprise Value | 309.8M | 1.0B | 1.4B | 797.4M | 717.7M | 753.6M |
BioLife Fundamentals
Return On Equity | -0.19 | ||||
Return On Asset | -0.0833 | ||||
Profit Margin | (0.46) % | ||||
Operating Margin | (0.41) % | ||||
Current Valuation | 769.7 M | ||||
Shares Outstanding | 45.3 M | ||||
Shares Owned By Insiders | 3.53 % | ||||
Shares Owned By Institutions | 96.47 % | ||||
Number Of Shares Shorted | 3.1 M | ||||
Price To Earning | 173.59 X | ||||
Price To Book | 2.21 X | ||||
Price To Sales | 5.22 X | ||||
Revenue | 143.27 M | ||||
Gross Profit | 54.07 M | ||||
EBITDA | (45.24 M) | ||||
Net Income | (66.43 M) | ||||
Cash And Equivalents | 46.55 M | ||||
Cash Per Share | 1.09 X | ||||
Total Debt | 42.69 M | ||||
Debt To Equity | 0.06 % | ||||
Current Ratio | 3.55 X | ||||
Book Value Per Share | 7.48 X | ||||
Cash Flow From Operations | (12.5 M) | ||||
Short Ratio | 9.14 X | ||||
Earnings Per Share | (1.52) X | ||||
Price To Earnings To Growth | 65.38 X | ||||
Target Price | 23.13 | ||||
Number Of Employees | 409 | ||||
Beta | 1.69 | ||||
Market Capitalization | 778.71 M | ||||
Total Asset | 412.71 M | ||||
Retained Earnings | (313.34 M) | ||||
Working Capital | 78.43 M | ||||
Current Asset | 6.97 M | ||||
Current Liabilities | 1.73 M | ||||
Net Asset | 412.71 M |
About BioLife Solutions Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioLife Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioLife Solutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioLife Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with BioLife Solutions
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioLife Solutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Solutions will appreciate offsetting losses from the drop in the long position's value.Moving together with BioLife Stock
0.69 | CVS | CVS Health Corp Sell-off Trend | PairCorr |
Moving against BioLife Stock
0.66 | ELYM | Eliem Therapeutics Upward Rally | PairCorr |
The ability to find closely correlated positions to BioLife Solutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioLife Solutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioLife Solutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioLife Solutions to buy it.
The correlation of BioLife Solutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioLife Solutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioLife Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioLife Solutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out BioLife Solutions Piotroski F Score and BioLife Solutions Altman Z Score analysis. For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.Note that the BioLife Solutions information on this page should be used as a complementary analysis to other BioLife Solutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for BioLife Stock analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is BioLife Solutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLife Solutions. If investors know BioLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.4 | Earnings Share (1.52) | Revenue Per Share 3.277 | Quarterly Revenue Growth (0.26) | Return On Assets (0.08) |
The market value of BioLife Solutions is measured differently than its book value, which is the value of BioLife that is recorded on the company's balance sheet. Investors also form their own opinion of BioLife Solutions' value that differs from its market value or its book value, called intrinsic value, which is BioLife Solutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLife Solutions' market value can be influenced by many factors that don't directly affect BioLife Solutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioLife Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.